LZG: Pump, Infusion, Insulin

Product code LZG, “Pump, Infusion, Insulin” in FDA's classification database, is a Class II device type under 21 CFR 880.5725 (infusion pump), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 85 clearances under LZG, 29 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
LZG
Regulation
21 CFR 880.5725
Class
II
Panel
General Hospital
Clearances
85
Most recent
Sep 2, 2026
Median review, last 2 years
107 days
Third-party review
Not eligible
Implant
No

What it covers

An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner. The device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically. The device may also operate using a constant force to propel the fluid through a narrow tube which determines the flow rate. The device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm.

The identification in 21 CFR 880.5725, infusion pump. FDA gives LZG no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K262153Pivot Insulin Delivery SystemModular Medical, Inc.Sep 2, 2026Traditional
K253534Pivot Insulin Delivery SystemModular MedicalApr 8, 2026Traditional
K240158Modular Medical MODD1 Insulin Delivery SystemModular Medical, Inc.Sep 4, 2024Traditional
K241622Extended Reservoir; MiniMed ReservoirMedtronic MinimedJul 2, 2024Special
K223372Omnipod GO Insulin Delivery DeviceInsulet CorporationApr 24, 2023Traditional
K210714Extended ReservoirMedtronic Minimed, Inc.Apr 6, 2022Traditional
K211575Omnipod® Insulin Management System, Omnipod DASH® Insulin Management SystemInsulet CorporationAug 13, 2021Traditional
K192659Omnipod Insulin Management System, Omnipod DASH Insulin Management SystemInsulet CorporationOct 21, 2019Traditional
K182630Omnipod Insulin Management System, Omnipod DASH Insulin Management SystemInsulet CorporationJan 8, 2019Traditional
K180045Omnipod DASH Insulin Management SystemInsulet CorporationJun 1, 2018Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 85 with a free account)

Clearances by year

29 LZG 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)2107
20242128
20231171
20221392
2021184
2019266
20181144
20171245
20164116
2015165
20144123
20132129
2012373
20114189

Who submits

10 applicants cleared a LZG device since 2011. 100% of the clearances went to applicants in United States. By type: Traditional 79%, Special 17% and Abbreviated 3%.

ApplicantClearances since 2011
Insulet Corporation11
Tandem Diabetes Care, Inc.7
Asante Solutions, Inc.2
Medtronic Minimed2
Modular Medical, Inc.2
M2 Group Holdings, Inc.1
Medtronic Minimed, Inc.1
Modular Medical1

How FDA classifies it

Class II (performance standards).

From 21 CFR 880.5725.

Standards

21 CFR 880.5725 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LZG clearances declared.

Ask about LZG

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about LZG

What is FDA product code LZG?

Product code LZG, “Pump, Infusion, Insulin” in FDA's classification database, is a Class II device type under 21 CFR 880.5725 (infusion pump), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 85 clearances under LZG, 29 of them since 2011.

How many 510(k) clearances are there under LZG?

FDA’s 510(k) database listed 85 clearances under LZG as of Oct 29, 2026, 29 of them decided since 2011; the most recent decision was Sep 2, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a LZG 510(k)?

For the 2 LZG clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 107 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most LZG clearances?

Since 2011: Insulet Corporation (11), Tandem Diabetes Care, Inc. (7), Asante Solutions, Inc. (2), Medtronic Minimed (2) and Modular Medical, Inc. (2). 10 applicants have cleared a LZG device in that time.

Sources

  1. FDA product classification: LZG · Product Classification database
  2. 21 CFR 880.5725: Infusion pump · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for LZG · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow LZGGet an email when FDA clears, recalls or publishes guidance for LZG devices.

Know what FDA already cleared.